Literature DB >> 17216259

Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome.

Rasheed Gbadegesin1, Bernward Hinkes, Christopher Vlangos, Bettina Mucha, Jinhong Liu, Jeff Hopcian, Friedhelm Hildebrandt.   

Abstract

Idiopathic nephrotic syndrome is a common pediatric kidney disease, 80% of all cases are steroid sensitive (SSNS). A significant proportion of children with SSNS will have a frequently relapsing or steroid-dependent course (FRNS/SDNS) that is associated with significant treatment-related morbidity. Mutations in NPHS2 account for more than 28% of all cases of steroid-resistant nephrotic syndrome (SRNS) and dominant mutations in WT1 for 5%; while mutations are absent from children with uncomplicated SSNS. Since FRNS/SDNS is phenotypically positioned within a spectrum between SSNS and SRNS, we hypothesized that heterozygous mutations of NPHS2 may be causing FRNS/SDNS. Mutational analysis of NPHS2 and WT1 was carried out in a single-center cohort of 20 children with FRNS/SDNS, ten children with uncomplicated SSNS (control), and 22 children with SRNS (control). Renal biopsy findings were available in 15/20 children with FRNS/SDNS and revealed IgM nephropathy, MCNS, and FSGS in six, five, and four children, respectively. Children with FRNS/SDNS were significantly younger at first presentation than those with SSNS and SRNS (median age: 3.0 years in FRNS/SDNS patients, 7.0 years in SSNS patients, and 5.0 in SRNS patients; p < 0.001). No NPHS2 or WT1 mutations were found in patients with FRNS/SDNS and uncomplicated SSNS. The hypothesis that FRNS/SDNS may be associated with heterozygous mutations in NPHS2 or WT1 was not confirmed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216259     DOI: 10.1007/s00467-006-0377-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Clinical features and outcome of childhood minimal change nephrotic syndrome: is genetics involved?

Authors:  Anne-Tiina Lahdenkari; Maija Suvanto; Eero Kajantie; Olli Koskimies; Marjo Kestilä; Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2005-06-21       Impact factor: 3.714

2.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

Authors:  N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

3.  Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.

Authors:  S L Schulman; B A Kaiser; M S Polinsky; R Srinivasan; H J Baluarte
Journal:  J Pediatr       Date:  1988-12       Impact factor: 4.406

Review 4.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  E M Hodson; J F Knight; N S Willis; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

5.  NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.

Authors:  Stefanie Weber; Olivier Gribouval; Ernie L Esquivel; Vincent Morinière; Marie-Josèphe Tête; Christophe Legendre; Patrick Niaudet; Corinne Antignac
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

6.  Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome.

Authors:  Rainer G Ruf; Michael Schultheiss; Anne Lichtenberger; Stephanie M Karle; Isabella Zalewski; Bettina Mucha; Anne Schulze Everding; Thomas Neuhaus; Ludwig Patzer; Christian Plank; Johannes P Haas; Fatih Ozaltin; Anita Imm; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

7.  A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution.

Authors:  Edgar Otto; Julia Hoefele; Rainer Ruf; Adelheid M Mueller; Karl S Hiller; Matthias T F Wolf; Maria J Schuermann; Achim Becker; Ralf Birkenhäger; Ralf Sudbrak; Hans C Hennies; Peter Nürnberg; Friedhelm Hildebrandt
Journal:  Am J Hum Genet       Date:  2002-08-29       Impact factor: 11.025

8.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

Authors:  Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

Review 9.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

10.  Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations.

Authors:  U Lenkkeri; M Männikkö; P McCready; J Lamerdin; O Gribouval; P M Niaudet; K Antignac C; C E Kashtan; C Homberg; A Olsen; M Kestilä; K Tryggvason
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

View more
  18 in total

1.  Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Authors:  Jianyong Zhong; Jacob B Whitman; Hai-Chun Yang; Agnes B Fogo
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 2.  Genetics of childhood steroid-sensitive nephrotic syndrome.

Authors:  Alana M Karp; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2016-07-29       Impact factor: 3.714

3.  The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis.

Authors:  Lu Lu; Heng Wan; Yi Yin; Wen-Jun Feng; Ming Wang; Yu-Cong Zou; Bo Huang; Dong-Tao Wang; Yin Shi; Yan Zhao; Lian-Bo Wei
Journal:  Int Urol Nephrol       Date:  2014-04-09       Impact factor: 2.370

Review 4.  Causes and pathogenesis of focal segmental glomerulosclerosis.

Authors:  Agnes B Fogo
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

5.  Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.

Authors:  Jutta Gellermann; Constantinos J Stefanidis; Andromachi Mitsioni; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2010-02-27       Impact factor: 3.714

Review 6.  Genetic testing in nephrotic syndrome--challenges and opportunities.

Authors:  Rasheed A Gbadegesin; Michelle P Winn; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2013-01-15       Impact factor: 28.314

7.  Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.

Authors:  Maija Suvanto; Jaakko Patrakka; Timo Jahnukainen; Pia-Maria Sjöström; Matti Nuutinen; Pekka Arikoski; Janne Kataja; Marjo Kestilä; Hannu Jalanko
Journal:  Clin Exp Nephrol       Date:  2016-08-29       Impact factor: 2.801

8.  Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome.

Authors:  Gil Chernin; Saskia F Heeringa; Rasheed Gbadegesin; Jinhong Liu; Bernward G Hinkes; Christopher N Vlangos; Virginia Vega-Warner; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2008-06-10       Impact factor: 3.714

Review 9.  Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era.

Authors:  Matthew G Sampson; Martin R Pollak
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

10.  Using Population Genetics to Interrogate the Monogenic Nephrotic Syndrome Diagnosis in a Case Cohort.

Authors:  Matthew G Sampson; Christopher E Gillies; Catherine C Robertson; Brendan Crawford; Virginia Vega-Warner; Edgar A Otto; Matthias Kretzler; Hyun Min Kang
Journal:  J Am Soc Nephrol       Date:  2015-11-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.